Hoffmann-La Roche Inc. patent applications published on September 26th, 2024
Jump to navigation
Jump to search
Contents
- 1 Patent applications for Hoffmann-La Roche Inc. on September 26th, 2024
- 1.1 SYSTEM AND METHOD FOR WHOLE-BODY BALANCE ASSESSMENT (18576270)
- 1.2 Novel Pyridine Compounds (18665797)
- 1.3 TREATMENT OF CANCER USING A HLA-A2/MAGE-A4 X CD3 BISPECIFIC ANTIBODY AND A 4-1BB (CD137) AGONIST (18742449)
- 1.4 HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE (18016289)
- 1.5 SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE ([[Hoffmann-La Roche Inc. (18455783). SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE simplified abstract|18455783]])
- 1.6 HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION (18656957)
- 1.7 BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE (18732998)
- 1.8 ANTISENSE OLIGONUCLEOTIDES TARGETING ACTL6B (18735668)
- 1.9 PREDICTION OF PHARMACOKINETIC CURVES (18579293)
Patent applications for Hoffmann-La Roche Inc. on September 26th, 2024
SYSTEM AND METHOD FOR WHOLE-BODY BALANCE ASSESSMENT (18576270)
Main Inventor
Ralf Josef JAEGER
Novel Pyridine Compounds (18665797)
Main Inventor
Mark CHAPMAN
TREATMENT OF CANCER USING A HLA-A2/MAGE-A4 X CD3 BISPECIFIC ANTIBODY AND A 4-1BB (CD137) AGONIST (18742449)
Main Inventor
Simon Patrick KEISER
HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE (18016289)
Main Inventor
Fabian DEY
SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE ([[Hoffmann-La Roche Inc. (18455783). SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE simplified abstract|18455783]])
Main Inventor
Cheol Keun CHUNG
HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION (18656957)
Main Inventor
Toshiyuki MORICHIKA
BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE (18732998)
Main Inventor
Harald DUERR
ANTISENSE OLIGONUCLEOTIDES TARGETING ACTL6B (18735668)
Main Inventor
Lars JOENSON
PREDICTION OF PHARMACOKINETIC CURVES (18579293)
Main Inventor
Dominic BRÄM
